PO · EP 14 · OUTCOMES
Before You Listen
Before You Listen
- Prerequisites: lower extremity amputation level vocabulary (Syme, transtibial [TT], transfemoral [TF], hip disarticulation), Medicare Functional Classification Levels (K0-K4) and their component templates from earlier episodes, and a working understanding of basic exercise physiology (oxygen consumption, walking speed, heart rate).
- Runtime: 58 minutes 45 seconds.
- Topic in one line: the energy expenditure hierarchy from Syme to bilateral TF and the vascular-versus-traumatic premium at every level, the rate-versus-cost distinction with self-selected walking speed as the compensatory mechanism, the K-level system with its 2024 K2 microprocessor knee (MPK) coverage expansion and five well-defined limitations, the Amputee Mobility Predictor (AMP) with its uniquely high reliability and pre-prosthetic predictive value, the patient-reported outcome batteries (PLUS-M, ABC, OPUS, Houghton, SCS, PEQ, TAPES) with the COMPASS recommended set, and the functional prognosis grid that anchors prosthetic prescription and counseling.
Vignette. A 54-year-old man underwent a left transfemoral amputation 6 months ago after a motorcycle crash. He has no diabetes, no peripheral arterial disease, and a strong premorbid activity history. His current Amputee Mobility Predictor with prosthesis (AMPPRO) score is in the upper third of published norms, his Six-Minute Walk Test (6MWT) distance is 432 meters, and his Activities-specific Balance Confidence (ABC) Scale score is 78%. His Socket Comfort Score (SCS) on the most recent visit was 4 of 10. He is requesting a microprocessor knee (MPK) and asks how oxygen cost compares to his pre-amputation baseline. His Medicare K-level was assigned as K2 by his prosthetist on the basis of “limited community ambulation.”
How should you interpret his AMPPRO and 6MWT in the context of K-level assignment, what does an ABC score of 78% indicate about fall risk, why is the SCS less reliable than the other measures, and what changed in September 2024 that affects his MPK candidacy?
(Answer at the end of this chapter)
Section 1: The Energy Expenditure Hierarchy and the Rate-Versus-Cost Trap
Bottom line: walking energy cost rises with more proximal amputation level and is higher in vascular than traumatic amputees at every level; the hierarchy from least to most demanding is Syme < unilateral TT < bilateral TT < unilateral TF < bilateral TF, with hip disarticulation in the 100-200% range; amputees self-select a slower walking speed to keep oxygen consumption rate near normal, but oxygen cost per meter is elevated.
The metabolic cost of walking with a prosthesis increases with more proximal amputation levels and with vascular versus traumatic etiology. This relationship, originally established by Waters and colleagues (1970s-1990s) and confirmed by modern meta-analyses, has direct implications for prosthetic prescription, rehabilitation goals, and prognosis. Two energy measures are clinically important and often confused. Oxygen consumption rate (mL O2/kg/min) measures metabolic demand per unit time. Oxygen cost (mL O2/kg/m) measures metabolic expense per unit distance traveled and accounts for walking speed; higher values mean it takes more energy to cover each meter.
The board concept tested repeatedly: amputees self-select a walking speed that keeps oxygen consumption rate near comfortable levels. As amputation level increases, patients walk more slowly to keep RATE within tolerable limits, but because they cover less distance per unit of energy, oxygen COST per meter increases. This compensatory mechanism explains why oxygen consumption rate may appear near-normal while oxygen cost per meter is clearly elevated. A vignette describing a TF amputee’s near-normal oxygen consumption rate during walking is not asking whether the patient walks efficiently; it is asking whether the test-taker recognizes that the slower self-selected speed has artificially preserved the rate measure while cost per meter remains elevated.
The energy expenditure hierarchy is among the most-tested facts in the prosthetic domain. Syme amputation produces minimal increase. Unilateral TT traumatic raises walking energy 10-25% with 10-15% speed reduction; unilateral TT vascular raises it 20-40%. Bilateral TT raises it approximately 41% with speed decreased 20-30%. Unilateral TF traumatic raises it 60-70% with 30-40% speed decrease; unilateral TF vascular raises it 65-100%. Bilateral TF raises energy greater than 200% above normal with speed reduced more than 50%, often making patients non-ambulatory. Hip disarticulation raises energy 100-200% with greater than 40% speed reduction. The 2019 PLOS ONE meta-analysis confirmed oxygen cost values of 0.15 mL/kg/m for able-bodied and unilateral TT, 0.18 for unilateral TF (20% increase), and 0.24 for bilateral TF (60% increase). Vascular amputees consistently demonstrate higher metabolic costs than traumatic at the same level.
For higher-level amputations, particularly bilateral TF, wheelchair mobility may be more energy-efficient than prosthetic ambulation. Wheelchair propulsion on level ground requires metabolic energy roughly comparable to or somewhat lower than normal walking, making it the more practical primary mobility device when bilateral TF demands exceed cardiovascular capacity. Cane use increases energy expenditure approximately 10-15% above normal. Bilateral 3-point crutch walking increases it 40-60%. Swing-through gait can increase it 75-100% or more, requiring upper extremity strength that exceeds many patients’ reserve.
Advanced prosthetic technology reduces metabolic demand. The C-Leg significantly reduces oxygen consumption at typical and fast speeds versus non-microprocessor knees. The Rheo Knee produces a 5% metabolic reduction versus the Mauch Knee and 3% versus C-Leg. MPK users demonstrate significantly increased physical activity in free-living environments, indicating that reduced per-step energy cost translates to greater daily activity. Reduced cognitive demand during ambulation is another MPK benefit. Powered ankle-foot systems (BiOM/Empower) reduce metabolic rate by 16% in highly active users with a 15% faster self-selected speed, though not all patients benefit equally.
High Yield; Energy expenditure hierarchy
- Hierarchy (least → most): Syme < unilateral TT < bilateral TT < unilateral TF < bilateral TF.
- Hip disarticulation sits between unilateral TF and bilateral TF (100-200% increase).
- Vascular > traumatic at every level.
- Bilateral TF: >200% above normal; walking speed cut by more than half; often non-ambulatory.
- Oxygen consumption RATE (mL/kg/min) = per minute; oxygen COST (mL/kg/m) = per meter.
- Self-selected slower speed keeps RATE near normal; COST per meter is elevated.
- Able-bodied O2 cost = 0.15 mL/kg/m; unilateral TF 0.18; bilateral TF 0.24 (2019 PLOS ONE meta-analysis).
- Wheelchair propulsion is roughly comparable to or lower than normal walking; often more efficient than bilateral TF prosthetic ambulation.
- Cane ~10-15% energy increase; bilateral crutches 3-point ~40-60%; swing-through 75-100%+.
- C-Leg reduces O2 consumption; Rheo = 5% reduction vs Mauch, 3% vs C-Leg; Empower = 16% reduction in active users with 15% faster speed.
Board Trap — Near-normal oxygen consumption RATE does not mean efficient walking
A vignette gives a TF amputee whose oxygen consumption rate during walking is near able-bodied values and asks whether the prosthesis “minimizes energy cost.” The trap is to pick yes. The discriminator: the near-normal rate reflects a slower self-selected speed, not improved efficiency. Oxygen cost per meter is the efficiency measure and is clearly elevated in TF amputees (0.18 vs 0.15 mL/kg/m for able-bodied). The patient is offsetting the metabolic penalty by walking more slowly. The same logic applies to bilateral TF patients whose heart rate and oxygen consumption rate may seem manageable on a treadmill at slow speed but whose per-meter cost remains greater than 200% above normal.
You’re monitoring their oxygen consumption rate, their RPMs. You look at the monitor, and the rate looks near normal. A novice clinician might write in the chart, patient is walking efficiently. But they are totally missing the bigger picture. Their oxygen cost per meter is completely through the roof.
— PO-14 podcast, ~7:56